logo
logo
Sign in

Contract Pharmaceutical Fermentation Services Market Forecast by Demand, Size, Shares and Opportunities through 2018-2026

avatar
Steve Blade
Contract Pharmaceutical Fermentation Services Market Forecast by Demand, Size, Shares and Opportunities through 2018-2026

The contract pharmaceutical fermentation services market is anticipated to continue its steady growth on back of the evolving use of fermentation techniques to develop active pharmaceutical ingredients (API) coupled with active research studies, and progressive regulatory scenario. The global contract pharmaceutical fermentation services market is envisaged to account for over US$ 4 billion by 2026, according to a recent analysis by Fact.MR.

Each segment of the keyword market has been individually analyzed on the basis of pricing, distribution, and demand prospect for the following regions:

  • North America (Canada, US)
  • Latin America (Argentina, Mexico)
  • Europe (NORDIC, UK)
  • MEA and Japan
  • APEJ (China, India)

Funding for early stage advanced biotechnology is increasing and companies commercializing fermentation-sourced technologies are either building their own demonstration-scale facility or using existing contract manufacturing organizations (CMOs). Several pharmaceutical companies are increasingly leveraging contract pharmaceutical fermentation services, which as per Fact.MR is likely to contribute over nearly US$ 2,400 million by value by 2026-end.

The Fact.MR study opines that the growing prevalence of various diseases has been accelerating demand for pharmaceutical products which is further propelling pharmaceutical firms to associate with contract pharmaceutical fermentation services’ providers. Together they can introduce highly unique and advanced molecules at a fast pace. Furthermore, the growing prevalence of a wide range of diseases, such as diabetes, cancer, hemophilia, rheumatoid arthritis, myocardial infarction, anemia, etc., has triggered demand for bulk pharmaceutical products with myriad applications in disease management.

You can Request an Example Copy from here - https://www.factmr.com/connectus/sample?flag=S&rep_id=1517

The Fact.MR report tracks the contract pharmaceutical fermentation services market for the forecast period 2018-2026. According to the report, the contract pharmaceutical fermentation services market is projected to grow at 5.9% CAGR through 2026. As per the American Diabetes Association (ADA), over 30 million Americans developed diabetes in 2015, which is 9.4% of the total population. The ADA concluded that nearly 1.5 million Americans get diagnosed with diabetes every year. The Fact.MR study opines that drug commercialization to CMOs/CDMOs in tandem with growing focus to alleviate the operating costs via outsourcing of R&D is driving efficiency of value chain.

collect
0
avatar
Steve Blade
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more